文献速递其他结缔组织病

根据自身抗体状态对系统性硬化症进行分层可揭示不同的分子特征

Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures.
PubMed 文献 · Ann Rheum Dis · 2024-10-22

基于PRECISESADS横断面研究纳入的206例系统性硬化症患者,按抗着丝点抗体(ACA)和抗SCL70抗体状态分层,整合转录组、流式细胞、细胞因子和代谢组数据进行比较。SCL70阳性患者表现为弥漫性皮肤硬化和肺纤维化等严重临床特征,并具有促炎和纤维化特征及肉碱代谢增加;ACA阳性患者则表现为免疫调节和组织稳态特征及磷脂代谢增加。

要点

  • SCL70阳性患者有弥漫性皮肤硬化和肺纤维化等严重表现,转录组呈促炎和纤维化特征。
  • ACA阳性患者呈免疫调节和组织稳态特征,磷脂代谢增加。
  • 血清学状态或可作为区分疾病严重程度及指导治疗策略的潜在因素。

核心结论

  • 系统性硬化症患者根据血清学状态呈现不同的生物学特征,血清学状态可能是疾病严重程度的区分因素,并可能与个体化治疗策略及未来研究方向相关。

研究设计与样本

  • PRECISESADS横断面研究纳入206例系统性硬化症患者,按抗着丝点抗体(ACA)和抗SCL70抗体状态分层。
  • 综合分析转录组、流式细胞、细胞因子和代谢组数据以刻画组间差异。

主要发现

  • SCL70抗体阳性患者具有弥漫性皮肤硬化和肺纤维化等严重临床特征,并呈现独特的转录组谱。
  • SCL70抗体阳性患者表现出促炎和纤维化特征,伴组织重塑受损和肉碱代谢增加。
  • ACA阳性患者表现出免疫调节和组织稳态特征,并伴磷脂代谢增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is a heterogeneous disease, complicating its management. Its complexity and the insufficiency of clinical manifestations alone to delineate homogeneous patient groups further challenge this task. However, autoantibodies could serve as relevant markers for the pathophysiological mechanisms driving the disease. Identifying specific immunological mechanisms based on patients' serological statuses might facilitate a deeper understanding of the diversity of the disease. METHODS: A cohort of 206 patients with SSc enrolled in the PRECISESADS cross-sectional study was examined. Patients were stratified based on their anti-centromere (ACA) and anti-SCL70 (SCL70) antibody statuses. Comprehensive omics analyses including transcriptomic, flow cytometric, cytokine and metabolomic data were analysed to characterise the differences between these patient groups. RESULTS: Patients with SCL70 antibodies showed severe clinical features such as diffuse cutaneous sclerosis and pulmonary fibrosis and were biologically distinguished by unique transcriptomic profiles. They exhibit a pro-inflammatory and fibrotic signature associated with impaired tissue remodelling and increased carnitine metabolism. Conversely, ACA-positive patients exhibited an immunomodulation and tissue homeostasis signature and increased phospholipid metabolism. CONCLUSIONS: Patients with SSc display varying biological profiles based on their serological status. The findings highlight the potential utility of serological status as a discriminating factor in disease severity and suggest its relevance in tailoring treatment strategies and future research directions.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Rouvière B, Le Dantec C, Bettacchioli E, et al. Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures. Ann Rheum Dis. 2024. PMID: 39438128. doi:10.1136/ard-2024-225925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。